Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Director Sangeeta N. Bhatia Sells 242 Shares

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) Director Sangeeta N. Bhatia sold 242 shares of the firm’s stock in a transaction dated Friday, October 6th. The stock was sold at an average price of $360.00, for a total transaction of $87,120.00. Following the completion of the sale, the director now directly owns 4,144 shares […]

Related Keywords

Sangeetan Bhatia ,Sanfordc Bernstein , ,Morgan Stanley ,Vertex Pharmaceuticals ,Securities Exchange Commission ,Institutional Trading Of Vertex Pharmaceuticals ,Quarter For Vertex Pharmaceuticals ,Ae Wealth Management ,News Ratings For Vertex Pharmaceuticals Daily ,Trinity Legacy Partners ,Adviser Investments ,Geneos Wealth Management Inc ,Vertex Pharmaceuticals Incorporated ,Vertex Pharmaceuticals Trading ,Get Free Report ,Director Sangeeta ,Exchange Commission ,Pharmaceuticals Incorporated ,Wealth Management ,Legacy Partners ,Vertex Pharmaceuticals Daily ,Nasdaq Vrtx ,Vrtx ,Medical ,92532f10 ,Insider Trading ,Nsider Trades ,Stocks ,